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Abstract
Background: Heteroplasmic mitochondrial 3697G>A mutation has been associated 
with leber hereditary optic neuropathy (LHON), mitochondrial encephalopathy, lac-
tic acidosis and stroke‐like episodes (MELAS), and LHON/MELAS overlap syn-
drome. However, homoplasmic m.3697G>A mutation was only found in a family 
with Leigh syndrome, and the phenotype and pathogenicity of this homoplasmic 
mutation still need to be investigated in new patients.
Methods: The clinical interviews were conducted in 12 individuals from a multiple‐
generation inherited family. Mutations were screened through exome next‐genera-
tion sequencing and subsequently confirmed by PCR‐restriction fragment length 
polymorphism. Mitochondrial complex activities and ATP production rate were 
measured by biochemical analysis.
Results: The male offspring with bilateral striatal necrosis (BSN) were characterized 
by severe spastic dystonia and complete penetrance, while the female offspring pre-
sented with mild symptom and low penetrance. All offspring carried homoplasmic 
mutation of NC_012920.1: m.3697G>A, p.(Gly131Ser). Biochemical analysis re-
vealed an isolated defect of complex I, but the magnitude of the defect was higher in 
the male patients than that in the female ones. The ATP production rate also exhib-
ited a similar pattern. However, no possible modifier genes on the X chromosome 
were identified.
Conclusion: Homoplasmic m.3697G>A mutation could be associated with BSN, 
which expanded the clinical spectrum of m.3697G>A. Our preliminary investiga-
tions had not found the underlying modifiers to support the double hit hypothesis, 
while the high level of estrogens in the female patients might exert a potential com-
pensatory effect on mutant cell metabolism.
K E Y W O R D S
bilateral striatal necrosis, homoplasmy, mitochondrial DNA mutation, sex bias
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1 |  INTRODUCTION
Bilateral striatal necrosis (BSN) is a heterogeneous group of 
neurodegenerative diseases named after the distinctive neu-
roradiological features (Lim, 2009). The main neurological 
findings are characterized by symmetrical degeneration of 
putamen, caudate nucleus, and globus pallidus occasionally. 
The pathogenesis of BSN is heterogeneous and has been asso-
ciated with various acquired and hereditary causes (Chokshi, 
Aygun, & Mullins, 2014). Hereditary striatal degeneration can 
be inherited as an autosomal dominant, autosomal recessive, or 
mitochondrial disorder (Tonduti et al., 2016). Adult‐onset auto-
somal‐dominant BSN is caused by mutations in the phosphodi-
esterase 8B (PDE8B, OMIM #603390) gene on chromosome 
5q13 (Appenzeller et al., 2010). Autosomal‐recessive BSNs are 
associated with mutations in several genes such as solute carrier 
family 25 member 19 (SLC25A19, OMIM #606521) (Spiegel 
et al., 2009), nucleoporin 62 (NUP62, OMIM #605815) 
(Bianciardi et al., 2016), adenosine deaminase RNA specific 
(ADAR1, OMIM: 146920) (La Piana et al., 2014), and protein 
Vac14 homolog (VAC14, OMIM #604632) (Stutterd et al., 
2017). Mitochondrial BSNs are caused by mutations in both mi-
tochondrial and nuclear genes associated with the maintenance 
of mitochondrial function (Binder et al., 2003; Thyagarajan, 
Shanske, Vazquez‐Memije, Vivo, & DiMauro, 1995).
Several mitochondrial DNA (mtDNA) mutations associ-
ated with defects of oxidative respiratory chain enzymes were 
linked with infantile‐onset BSNs (Hirayanagi et al., 2017; 
Tarnopolsky, Meaney, Robinson, Sheldon, & Boles, 2013). 
The heteroplasmic mutation of NC_012920.1: m.3697G>A, 
p.(Gly131Ser) in the mitochondrial NADH dehydrogenase 
subunit 1 (MTND1, OMIM #516000) gene was identified in 
patients with mitochondrial encephalomyopathy, lactic aci-
dosis and stroke‐like episodes (MELAS) (Kirby et al., 2004), 
Leber's hereditary optic neuropathy (LHON) (Spruijt et al., 
2007), LHON/MELAS overlap syndrome (Blakely et al., 
2005), and Stüve‐Wiedemann syndrome (Morava, Hamel, Hol, 
Rodenburg, & Smeitink, 2006). In contrast, the homoplas-
mic m.3697G>A mutation was found as a causation of Leigh 
syndrome (LS) in a Japanese family (Negishi et al., 2014), in 
which the affected individuals exhibited early childhood‐onset 
rigidity of the upper and lower limbs due to bilateral basal 
ganglion and brainstem degeneration. Herein, we investigated 
the clinical features, brain MRI changes, genetic findings, and 
mitochondrial function in a family with BSN and assessed its 
association with homoplasmic m.3697G>A mutation.
2 |  MATERIALS AND METHODS
2.1 | Ethical compliance
The clinical examinations and genetic analyses in this fam-
ily were conducted after the written informed consent was 
provided by every examined individual according to the 
Declaration of Helsinki. The study was approved by the 
institutional ethical review board of the Peking University 
People's Hospital.
2.2 | Patients
The index patient was a 20‐year‐old man (III3) from a non-
consanguineous family (Figure 1). He had rigidity on the left 
limbs since he was 6 years old. The dystonia insidiously pro-
gressed and resulted in clumsy movements of the left limbs, 
but the symptoms maintained a stable condition since the age 
of eight. Eight months ago, the right limbs started exhibiting 
similar rigidity. He presented with dysarthria, dysphagia, and 
difficulty of standing steadily. The patient had no complaints 
about muscle weakness, myalgia, or numbness. Mini‐mental 
state examination (MMSE) revealed a moderate cognitive 
disability (17/30). Physical examination revealed scoliosis, 
finger joint contracture, left ankle deformity, and an in-
creased muscle tone of the neck and all of the limbs. Muscle 
strength graded 5/5 in the right limbs and 4/5 in the left limbs 
(Medical Research Council Scale). The deep tendon reflexes 
of the lower limbs were enhanced. The Babinski sign was 
positive on the left side. His visual acuity and auditory ability 
were unimpaired. The pinprick, position, and vibration sen-
sations were normal.
The elder aunt's son (III2) was 23 years old, and he dis-
played spastic gait at the age of five. He developed upper limb 
spasticity, lower limb tightness, and walking difficulty at the 
age of 10. He was wheelchair‐bound when he was referred 
to our clinic at the age of 26. His cognitive performance was 
mildly decreased (MMSE: 20/30). Physical examination re-
vealed enhanced muscle tone. The sensations were intact, and 
the optic neuropathy was not detected.
The index patient's young brother (III5) was 16 years 
old. He had similar symptoms with the index patient. The 
age of onset was four. Clinical symptoms included moder-
ate cognitive ability (MMSE: 17/30), scoliosis, finger joint 
F I G U R E  1  The pedigree of family: squares, male; circles, 
female; black symbols, affected; arrow, the index
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contracture, deformity of the ankle joint, and enhanced mus-
cle tone. No sensations or optic nerves were impaired.
The mother (II4) was 47 years old and started having 
slight clumsiness of left upper limbs at the age of 18, but 
the symptoms had been stable since she was 20 years old. 
Physical examination revealed an enhanced muscle tone on 
the left upper limbs. No other abnormalities were detected.
The elder aunt (II1) was reported to have clumsy move-
ment of right limbs since 17 years old, and the symptoms 
had not progressed since she was 20 years old. The grand-
mother (I1) had rigid hands in her 20 s, but quickly became 
progression‐free. The young aunt (II6) had no complaints of 
any symptoms, but her son (III7) had a similar clumsy gait as 
that of the index patient and died of severe injury at age 17. 
The detailed data were summarized in Table 1. The family 
individuals (III1, III4, III6, III8, and III9) were not found to 
have any symptoms or abnormal signs.
2.3 | Brain MRI
Brain MRI was conducted by a 3.0‐T MR scanner 
(Seimen). Conventional T1‐weighted spin echo (T1WI) 
sequences were obtained with the following parameters: 
repetition time (TR) = 250 ms, echo time (TE) = 2.5 ms, 
FoV = 306 × 220 mm; conventional T2‐weighted spin 
echo (T2WI) sequences: TR = 4,000 ms, TE = 157 ms, 
FoV = 306 × 220 mm; fluid‐attenuated inversion recov-
ery (FLAIR) sequences: TR = 8,000 mm, TE = 79 mm, 
FoV = 306 × 220 mm; diffusion tensor imaging (DTI): 
TR = 7,700 mm, TE = 104 mm, FoV = 315 × 227 mm; 
magnetic resonance spectroscopy (MRS): TR = 1,900 mm, 
TE = 2.3 mm, FoV = 695 × 500 mm. The slice thickness 
was 5 mm, and the slice gap was 6.5 mm.
2.4 | Mutation analysis
Genomic DNA was extracted from peripheral blood samples 
of family members II4, III3, and III4. Initially, the genetic 
test was conducted through exome next‐generation sequenc-
ing (NGS). Targeted exon enrichment was performed using 
SureSelect Human All Exon V4 (Agilent Technologies, 
Santa Clara, CA, USA). The exon‐enriched DNA libraries 
were subjected to paired‐end sequencing with the Hiseq2000 
platform (Illumina, Inc., San Diego, CA, USA). Calls with 
variant quality <20 were filtered out, and 95% of the targeted 
bases were covered sufficiently to pass our thresholds for 
calling single‐nucleotide polymorphisms (SNP) and small 
insertions or deletions.
Whole mtDNA sequencing was conducted after long‐PCR 
amplification. Amplified fragment was directly sequenced 
using a BigDye ready reaction kit (Applied Biosystems, 
Foster City, CA, USA) and was run on an ABI 3700 automated 
T A B L E  1  The clinical features and the laboratory findings in the BSN family with homoplasmic m.3697G>A
Patient Age/gender Age at onset
Clinical 
features Optic symptoms MMSE Cerebral MRI Mutation
I1 73/F 20 Hands 
rigidity
None 24 NA NA
II1 50/F 17 Right 
limbs 
clumsy
None 30 Left hyperintensities 
of the putamen
Homoplasmic m.3697G>A
II4 47/F 18 Left limb 
rigidity
None 29 Right hyperintensities 
of the putamen
Homoplasmic m.3697G>A
II6 44/F NA None None 30 Normal Homoplasmic m.3697G>A
III1 25/F NA None None 30 Normal Homoplasmic m.3697G>A
III2 23/M 5 Spastic 
dystonia
None 20 Bilateral hyperintensi-
ties of the putamen
Homoplasmic m.3697G>A
III3 20/M 6 Spastic 
dystonia
None 17 Bilateral hyperintensi-
ties of the putamen
Homoplasmic m.3697G>A
III4 18/F NA None None 30 Normal Homoplasmic m.3697G>A
III5 16/M 4 Spastic 
dystonia
None 17 Bilateral hyperintensi-
ties of the putamen 
and caudate nucleus
Homoplasmic m.3697G>A
III6 9/F NA None None 27 Normal Homoplasmic m.3697G>A
III7 17a/M 5 Spastic 
dystonia
NA NA Bilateral hyperintensi-
ties of the putamen
NA
Notes. F: female; M: male; MMSE: mini‐mental state examination; NA: unavailable.
aThe patient died at the age of 17. 
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sequencer (Applied Biosystems). Identical mtDNA fragment 
from the family members (II1, II4, II6, III1, III2, III4, III5, 
and III6) was examined for the presence of the mutation.
In order to detect the mutant load of m.3697G>A, NGS 
targeted to MitoExome was performed using the blood and 
urine sediments of the index patient (III3) and the blood of 
member II4, III5, III6 (PrecisionMD Technology, Beijing, 
China). The average depth of reads for single nucleotide 
reached over 5,000 times, enabling the detection of hetero-
plasmic variants at levels of <0.1%. In addition, mutant load 
of m.3697G>A was further assessed by PCR‐restriction 
fragment length polymorphism (PCR‐RFLP). The mtDNA 
fragments were initially amplified using the primers as 
follows: forward 5′‐TACTTCACAAAGCGCCTTCC‐3′ 
and reverse 5′‐ATGAAGAATAGGGCGAAGGG‐3′, then 
cleaved by BclI restriction endonuclease (NEB, Ipswich, 
MA, USA), and finally separated by electrophoresis. The 
intensity of the bands was quantified by Gel‐Pro Analyzer 
4.0 (MediaCybernetics, Warrendale, PA, USA). GenBank 
NC_012920.1 was adopted as the reference sequence.
The mtDNA sequence of the index patient carrying 
the m.3697G>A mutation was initially analyzed through 
MitoTool software (www.mitotool.org/) and then assigned to 
the Asian mitochondrial haplogroups by using the nomencla-
ture of mitochondrial haplogroups (Tanaka et al., 2004).
2.5 | Biochemical analysis
B‐lymphocytes from several family individuals (II4, III3, 
III5, and III6) were immortalized as described previously 
(Hammerschmidt & Sugden, 1989). Individual oxidative 
phosphorylation system (OXPHOS) complexes were ex-
tracted from mitochondria using n‐dodecyl‐β‐d‐maltoside 
(Sigma, St Louis, MO, USA) with a detergent/protein ratio 
of 2.5 g/g. Proteins (60 μg) containing 0.5% Blue G‐250 
(Sigma) and 5% glycerol were separated via electrophoresis 
on 3%–11% gradient blue native polyacrylamide gels as pre-
viously described (Xu et al., 2017).
ATP production rate was assessed using an ATP mea-
surement kit (Molecular Probes, Carlsbad, CA, USA) ac-
cording to the manufacturer's instructions. To measure 
mitochondrial ATP level, cells were incubated with 10 mM 
glucose (Sigma) or 5 mM 2‐DG with 5 mM pyruvate for 
2 hr prior to the measurement. Fluorescence/lumines-
cence was measured using a VarioskanTM Flash Multimode 
Reader (Thermo Fisher Scientific, Waltham, MA, USA).
3 |  RESULTS
3.1 | Brain MRI features
Brain MRI of the index patient displayed high signal intensi-
ties in the bilateral putamen on T2WI and mildly high signal 
intensities on FLAIR images (Figure 2; III3). Abnormal sig-
nals in the bilateral putamen were also observed in the images 
of all other affected male individuals (Figure 2; III2, III5, 
and III7). In addition, high‐intensity signals in the bilateral 
caudate nucleus were observed in the images of patient III5 
(Figure 2; III5). The elder aunt (II1) only had a high‐intensity 
signal in the left putamen (Figure 2; II1), and the mother (II4) 
had high‐intensity signal only in the right putamen (Figure 2; 
II4). In contrast to the male individuals, the female patient II6 
(at age 45), patient III1 (at age 29), patient III4 (at age 18), 
and patient III6 (at age 9) had normal brain MRI images. The 
signal intensities were negatively related to enhancement in 
the lesions, but the lesions showed the fiber interruption on 
DTI images and severe decrease of n‐acetylaspartate (NAA) 
on MRS measure (Supporting Figure S1).
3.2 | Mitochondrial DNA mutation
The homoplasmic mutation of NC_012920.1: m.3697G>A, 
p.(Gly131Ser) was detected in the index patient (III3) through 
mtDNA Sanger sequence (Figure 3a), which changes a very 
evolutionarily conserved glycine into serine at 131 amino acid 
of MTND1 (p.Gly131Ser; Figure 3b). The same homoplasmic 
mutation was identified in the circulating lymphocytes from the 
available family individuals (II1, II3, II4, II6, III1, III2, III4, III5, 
and III6). Targeted NGS for MitoExome showed that the index 
patient had more than 99.9% of m.3697G>A mutation in the 
circulating lymphocytes, and more than 99.9% of m.3697G>A 
mutation in the urinary epithelium; the mother (II4) had more 
than 99.9% of m.3697G>A mutation in the circulating lympho-
cytes; and the asymptomatic sister (III4) had more than 99.9% of 
m.3697G>A mutation in the circulating lymphocytes (Table 2).
In the PCR‐RFLP analysis, the wild‐type MTND1 frag-
ment would be cleaved into two small fragments of 532 bp 
and 300 bp, while the mutant MTND1 fragment would be cut 
into three small fragments of 532 bp, 270 bp, and 30 bp. The 
PCR‐RFLP showed that no 300 bp fragment was detected in 
the samples from patient II4, III3, III4, and III5, which in-
dicated that the mutant loads of m.3697G>A were 100% in 
these patients (Figure 3c).
From the whole mtDNA sequencing of the blood from 
the index patient, the following polymorphisms were found: 
m.709T>C, m.3759A>G, m.5153A>G, m.5178C>T, 
m.9180A>G, m.10397A>G, m.15724A>G, m.16189T>C, 
and m.16519T>C. The results indicated that this family be-
longed to the mitochondrial haplogroup D5b1b, which was 
commonly found in Japan and North China. This haplogroup 
had been reported to be associated with schizophrenia, 
Parkinson disease, and diabetes in Japanese population, but 
had not been linked to BSN, LS, or LHON. Except for the 
homoplasmic mutation m.3028A>T, all the other polymor-
phisms were known as variations of the Cambridge sequence 
(Supporting Information Table S1).
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F I G U R E  2  Brain MRI findings of 
family individuals. Magnetic resonance 
images of patients showed high‐intensity 
signals in the bilateral putaminal areas on 
both T2‐weighted (T2) and fluid‐attenuated 
inversion recovery (FLAIR) images in male 
patients III2, III3, III5, and III7; unilateral 
putaminal areas in female patients II1 and 
II4; and normal cerebral structure in other 
female individuals II6, III1, III4, and III6
F I G U R E  3  The homoplasmic mutation of NC_012920.1: m.3697G>A, p.(Gly131Ser) was found in the index patient (III3), his mother 
(II4), and his sister (III4), but not his father (II3) (a). The mutation changes a very evolutionarily conserved glycine into serine at 131 amino acid of 
MTND1 (b). The homoplasmy of m.3697G>A mutation was confirmed by PCR‐RFLP. The wild‐type fragment will be cleaved into two fragments 
of 532 bp and 300 bp, while the mutant fragment will be cut into three fragments of 532 bp, 270 bp, and 30 bp (c)
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3.3 | Biochemical results
To investigate the pathogenic role of m.3697G>A and 
the possible cause of the sex bias, the levels of OXPHOS 
complexes were measured in immortalized lymphocytes 
derived from several family individuals. Blue Native 
PAGE/Immunoblot analysis revealed a significantly de-
creased level of OXPHOS complex I in the lymphocytes 
of the male patients III3 and III5 compared with that of 
the female patients II4, III6, and a control, but the other 
OXPHOS complexes were not impaired (Figure 4a,b). 
Consistently, the ATP production rate was significantly 
decreased in the male patient III3 and III5 compared 
with that of the female patient II4, III6, and a control 
(Figure 4c).
3.4 | Genomic DNA mutation
Initially, the exome NGS did not find variants in the PDE8B 
gene for autosomal‐dominant striatal degeneration, or in the 
SLC25A19, NUP62, ADAR1, and VAC14 genes for autoso-
mal‐recessive BSN. In addition, no variants were found in the 
NADH:Ubiquinone oxidoreductase subunit A1 (NDUFA1, 
OMIM #300078) gene or in the NADH:Ubiquinone oxi-
doreductase subunit B11 (NDUFB11, OMIM #300403) 
gene, both of which were located on the X chromosome. 
Owing to the obvious female bias in the family, we carefully 
compared the variants on the X chromosome between the 
index patient (III3) and his sister (III4) in the exome data-
base. The filtering strategy was followed as a hemizygote in 
the index patient and a heterozygote in his sister on the X 
T A B L E  2  The targeted next‐generation sequencing for mitochondrial DNA in the index patient (III3), his mother (II4), and his younger sister 
(III4)
Sample Read G (wt) Read A Read C Read T Heteroplasmy (%)
Patient
Blood 0 6,016 1 1 99.97
Urine 1 5,381 0 1 99.96
Mother blood 0 5,958 0 1 99.98
Sister blood 1 5,839 1 0 99.97
Notes. Data are the number of reads for the specific nucleotide (A, C, G, T) with G as the wild type (wt) and A as the mutant. The percentage of heteroplasmy is the ratio 
of mutant/wt. The very low proportion of G, C, and T reads likely represents nonspecific sequence “noise.” The true percentage of heteroplasmy is more than 99.9% and 
likely represents homoplasmy for the mutant.
F I G U R E  4  Blue Native PAGE blot revealed an isolated decrease of OXPHOS complex I in the male patients III3 and III5 compared with that 
of the female patients II4, III6, and a control; the other OXPHOS complexes were not impaired (a,b). The ATP production rate was significantly 
decreased in the male patients III3 and III5 compared with that of the female patients II4, III6, and a control (c). C: control; CI: complex I; CII: 
complex II; CIII: complex III; CIV: complex IV; CV: complex V
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chromosome. We identified two candidate genes (Supporting 
Information Table S2). The shroom family member 2 
(SHROOM2, OMIM #300103) gene showed a missense 
mutation NC_000023.11:c.1426G>C, p.(Gly476Arg) with 
a low allele frequency of 0.001796 in the gnomAD data-
base. The leucine zipper protein 4 (LUZP4, OMIM #300616) 
gene had a missense mutation NM_016383.4:c.382A>G, 
p.(Asn128Asp) with a low allele frequency 0.0002301 in the 
gnomAD database.
4 |  DISCUSSION
The heteroplasmic m.3697G>A mutation had been associ-
ated with MELAS (Kirby et al., 2004), LHON (Spruijt et 
al., 2007), LHON/MELAS overlap syndrome (Blakely et 
al., 2005), and synergetic effects for Stuve‐Wiedemann syn-
drome (Morava et al., 2006). In contrast, the homoplasmic 
m.3697G>A mutation was only reported in a family with 
LS (Negishi et al., 2014). By reviewing the literatures about 
m.3697G>A mutation (Supporting Information Table S3), 
we found that the patient 1 reported by Negishi and col-
leagues indeed presented with a phenotype of early child‐
onset BSN and relatively good prognosis (Negishi et al., 
2014), and the younger brother described by Spruijt and col-
leagues should be patient with early child‐onset BSN and a 
stationary condition (Spruijt et al., 2007). Our patients also 
presented with child‐onset spastic dystonia selectively in-
volved in the bilateral putaminal lesions. At least eight other 
variants of mtDNA could cause BSN that was characterized 
by spastic dystonia (Campos et al., 1997; Solano et al., 2003). 
Among those variants, the phenotype of m.14459G>A mu-
tation showed a great similarity with that of m.3697G>A. 
The patients with m.14459G>A mutation also presented with 
LHON, dystonia, and LS/Leigh‐like syndrome (LLS) (Kim, 
Ki, & Park, 2010; Ronchi et al., 2011). Indeed, optic atrophy, 
childhood‐onset dystonia, BSN, LLS, and LS can be consid-
ered as a phenotypic spectrum of severity likely determined 
by the mutational heteroplasmy (Gropman et al., 2004).
The nomenclature of BSN is based on neuroradiological 
alterations, especially the degeneration of bilateral putamen, 
globus pallidus, and caudate nucleus. Our male patients 
showed bilateral putamen degeneration, except for the patient 
III5 who had an additional involvement of bilateral caudate 
nucleus. However, the affected female patients only presented 
with unilateral putamen degeneration. The asymmetrical le-
sions were also observed in the LS patient with homoplasmic 
m.3697G>A mutation (Negishi et al., 2014). This phenom-
enon suggested that the basal ganglion lesions had great 
heterogeneity in patients with homoplasmic m.3697G>A 
mutation. The typical phenotype of LS is a subacute progres-
sive necrotizing encephalomyelopathy with poor prognosis 
characterized by bilateral symmetric necrosis of gray matter 
nuclei in the basal ganglia, diencephalons, cerebellum, or 
brainstem (Rahman et al., 1996). The radiological features 
of BSN overlapped greatly with, but not identical to those 
of LS. Therefore, the m.3697G>A mutation‐associated BSN, 
particularly the one confined to the putamen, might be con-
sidered as an abortive pattern of LS.
The disease severity and penetrance of mitochondrial dis-
eases have been considered the results of mutation loads. For 
example, cases with m.8993T>G homoplasmy at a high mu-
tation load caused LS, whereas lower mutation load resulted 
in a less severe phenotype (Sofou et al., 2018). Similarly, 
heteroplasmy of m.3697G>A might cause various mitochon-
drial disorders that presumably depended on the level of het-
eroplasmy. To our knowledge, homoplasmic mutation was 
only reported to be associated with LS (Negishi et al., 2014). 
In the current study, the individuals carrying homoplasmic 
m.3697G>A mutation presented with highly variable phe-
notypes, especially more severe clinical severity in the male 
patients than the females. The biochemical analysis revealed 
that the mutation caused an isolated defect of complex I, but 
the defect magnitude was higher in male patients than female 
ones, which can be the possible reason for the most strik-
ing discrepancy of clinical phenotype between the male and 
female patients. However, the underlying causes for the sex 
bias should be further explored.
Patients with different ethnic groups likely have differ-
ent mtDNA haplogroups, although a precise definition of 
the haplotypes is available in few subjects (Qu et al., 2010). 
In this family, there were 45 variants in the mitochondrial 
genome, which pointed to the haplogroup D5b1b. This hap-
logroup had been reported to be associated with schizophre-
nia, Parkinson disease, and diabetes in Japanese population 
(Tanaka et al., 2004). Although mitochondrial haplogroups 
could influence the phenotypic presentation of BSN and LS, 
no evidence could be found between m.3697G>A and haplo-
type D5b1b disclosed in our patients.
A double hit hypothesis of disease predicts that only 
those who also inherit an X‐linked recessive phenotype 
modifier will actually develop the mitochondrial disease 
(Chen, Chen, & Guan, 2015). Apparently, the sex bias in 
this BSN family suggested that one or more modifier genes 
on the X chromosome might be responsible for the phe-
notypic variability and incomplete penetrance. By exome 
NGS screening, we did not find any variants in the NDUFA1 
and NDUFB11 genes that encode the protein subunits of 
complex I on the X chromosome. We found two suspicious 
genes (Shroom2 and LUZP4) that closely co‐segregated 
with the phenotype in the family. Shroom2 is implicated 
in amiloride‐sensitive sodium channel activity that may be 
involved in endothelial cell morphology changes during 
cell spreading. Depletion of this gene results in an increase 
in endothelial sprouting, migration, and angiogenesis. This 
gene is highly expressed in the retina and may regulate the 
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biogenesis of melanosomes and promote their association 
with the apical cell surface by inducing gamma‐tubulin re-
distribution, but it is supposed not to be expressed in the 
brain tissue (Farber, Rizaldy, & Hildebrand, 2011). LUZP4 
is an export adapter that enhances the RNA‐binding activ-
ity of the nuclear RNA export factor NXF1 and can re-
store mRNA export function in cells compromised by loss 
of mRNA export adapters. It is highly expressed in cancer 
cells, but reported not to be expressed in the brain tissue 
(Viphakone et al., 2015). Therefore, the above genes were 
less likely to take synergetic effects on BSN, though they 
should be further investigated.
Significant sex bias had been universally described 
in the LHON pedigrees, in which the male offspring 
presented with more severe visual loss and higher pene-
trance, but the female offspring exhibited mild symptoms 
and low penetrance (Hudson et al., 2005). Similarly, no 
definite genetic modifiers were identified in these LHON 
patients. However, studies on LHON have revealed that 
estrogens could exert a potential compensatory effect on 
mutant cell metabolism through lowering oxidative stress 
and thus would reduce damage to the complex I proteins 
and increase ATP synthesis (Giordano et al., 2011). Future 
studies should be warranted to explore, yet it is uncertain 
whether estrogens can exert a potential effect on the phe-
notype of BSN.
In summary, this study identified homoplasmic 
m.3697G>A mutation as a cause of BSN and supported the 
role of MTND1 as a key player in the complex I. Although 
the female ancestors transmitted the BSN‐associated mtDNA 
mutation to all of their offspring, most females never pre-
sented with clinical symptoms and exhibited variably re-
duced penetrance with a sex bias that favored in the males. 
The preliminary investigations had not found the underlying 
genetic modifiers to support the double hit hypothesis, while 
the high level of estrogens in the female patients might exert 
a potential compensatory effect on mutant cell metabolism.
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